Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-089074

MELINTA THERAPEUTICS, INC. /NEW/ · MLNT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John Johnson
Director
Period of report
Jan 1, 2016
Accepted (ET)
Jan 5, 2016 · 5:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———10,000D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F7$31.13Jan 1, 2016A15,000A—Dec 31, 2025Common Stock15,00015,000D
Stock Option (Right to Buy)F1$23.51holding————Dec 31, 2024Common Stock15,00015,000D
Stock Option (Right to Buy)F2$2.09holding————Aug 9, 2019Common Stock22,10522,105D
Stock Option (Right to Buy)F3$2.09holding————Jul 28, 2020Common Stock6,6796,679D
Stock Option (Right to Buy)F4$7.62holding————Mar 19, 2022Common Stock15,00015,000D
Stock Option (Right to Buy)F5$6.79holding————Feb 3, 2023Common Stock15,00015,000D
Stock Option (Right to Buy)F6$13.10holding————Jan 7, 2024Common Stock15,00015,000D

Explanation of responses